{"id":"W3088751416","doi":"10.1016/j.annonc.2020.08.411","title":"309P Real-world effectiveness of alpelisib (ALP) + fulvestrant (FUL) compared with standard treatment among patients (Pts) with hormone-receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2–) PIK3CA-mutated (Mut) advanced breast cancer (ABC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Internal medicine; Oncology; Cohort; Clinical endpoint; Fulvestrant; Progression-free survival; Metastatic breast cancer; Clinical trial; Cancer; Chemotherapy; Breast cancer; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001777766,0.0007688717,0.00237982,0.0002403062,0.0001624701,0.00001267764,0.0002470347,0.000195165,0.0002728356],"category_scores_gemma":[0.00005216493,0.0005643636,0.0002360628,0.0008188329,0.001156416,0.0004805618,0.00006393954,0.0003904957,0.000005112098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001143057,"about_ca_system_score_gemma":0.0007821899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004458347,"about_ca_topic_score_gemma":0.001730297,"domain_scores_codex":[0.9960757,0.0006319659,0.0009123599,0.0009245471,0.0006789501,0.0007764519],"domain_scores_gemma":[0.9952048,0.000575786,0.001160421,0.0003826096,0.002128505,0.0005478775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3304777,0.005813529,0.4314488,0.001098938,0.008419983,0.0002661627,0.018662,0.002059139,0.09130357,0.0002413714,0.0004339389,0.1097749],"study_design_scores_gemma":[0.02985131,0.04018491,0.758383,0.0008821545,0.0003757164,0.00001743979,0.001080723,0.00002160741,0.1682369,0.00003286975,0.0003737696,0.0005595456],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908143,0.0002337819,0.0002532295,0.001871166,0.0001015425,0.002613426,0.003232715,0.0001148184,0.0007650105],"genre_scores_gemma":[0.996872,0.0003445345,0.001272239,0.0003770934,0.0001234595,0.0003526092,0.0004878422,0.000130586,0.00003962269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3269342,"threshold_uncertainty_score":0.9996808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0303983865183438,"score_gpt":0.3392094778581987,"score_spread":0.3088110913398548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}